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Many psychiatric diseases observed in humans have tenuous or absent analogs in other
species. Most notable among these are schizophrenia and autism. One hypothesis has
posited that these diseases have arisen as a consequence of human brain evolution,
for example, that the same processes that led to advances in cognition, language,
and executive function also resulted in novel diseases in humans when dysfunctional.
Here, the molecular evolution of the protein-coding regions of genes associated with
these and other psychiatric disorders are compared among species. Genes associated
with psychiatric disorders are drawn from the literature and orthologous sequences are
collected from eleven primate species (human, chimpanzee, bonobo, gorilla, orangutan,
gibbon, macaque, baboon, marmoset, squirrel monkey, and galago) and 34 non-primate
mammalian species. Evolutionary parameters, including dN/dS, are calculated for each
gene and compared between disease classes and among species, focusing on humans
and primates compared to other mammals, and on large-brained taxa (cetaceans,
rhinoceros, walrus, bear, and elephant) compared to their small-brained sister species.
Evidence of differential selection in humans to the exclusion of non-human primates was
absent, however elevated dN/dS was detected in catarrhines as a whole, as well as in
cetaceans, possibly as part of a more general trend. Although this may suggest that
protein changes associated with schizophrenia and autism are not a cost of the higher
brain function found in humans, it may also point to insufficiencies in the study of these
diseases including incomplete or inaccurate gene association lists and/or a greater role of
regulatory changes or copy number variation. Through this work a better understanding
of the molecular evolution of the human brain, the pathophysiology of disease, and the
genetic basis of human psychiatric disease is gained.
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INTRODUCTION
Mental health disorders are common in the modern world, with
lifetime prevalence ranging from 1 in 6 to 1 in 2 (Kessler et al.,
2009). In the United States, roughly half of all Americans will suf-
fer from a mental health disorder in their lifetime (Kessler et al.,
2005); however understanding the causes of these diseases and
developing efficacious treatments have been difficult. There are
many reasons for these difficulties, but one particularly vexing
issue for basic scientists has been in the difficulty in develop-
ing reliable and translational animal models (Nestler and Hyman,
2010; Razafsha et al., 2013).
Why animal models of neuropsychiatric disorders are chal-
lenging is multifaceted. No small part of this is due to the fact
that the brain is incredibly complex and our understandings
still incomplete. Another major issue is in identifying analogous
behavioral phenotypes in animals; even seemingly straightfor-
ward behaviors like anxiety can be difficult to fully appreciate
(Steimer, 2011). Before any of these considerations, however,
lies the fundamental assumption that brains, their physiology,
connectivity, and development, work the same across animals
and that particular dysfunctions manifest similarly. The universal
validity of this assumption however has been challenged, particu-
larly as it relates to schizophrenia and autism.
Like other psychiatric diseases, schizophrenia and autism per-
sist in society despite negative fitness effects that would put suffer-
ing individuals at an evolutionary disadvantage. Schizophrenia,
which presents with characteristics ranging from delusions and
hallucinations to impaired communication and social function,
has a lifetime prevalence of roughly 0.5% (Goldner et al., 2002;
Saha et al., 2005; Perala et al., 2007). Autism too shows character-
istics similar to schizophrenia in its etiology and pathophysiology
(De Lacy and King, 2013). Characterized by cognitive deficits
ranging from impaired communication and social interaction to
restricted and/or repetitive behaviors, autism spectrum disorders
maintain a similar global prevalence of roughly 0.5%, skewed
toward males (Elsabbagh et al., 2012).
Evidence supports an interpretation that the origins of
schizophrenia and autism coincide with the divergence of mod-
ern humans (Crow, 1997; Horrobin, 1998; Burns, 2004). Despite
proposed evolutionary advantages such as enhanced creativity in
schizophrenia (Karlsson, 1984; Claridge et al., 1990; Post, 1994;
Nettle, 2001), more often it is surmised that neurodevelopmental
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disease persists as a maladaptive by-product of changes in the
brain that led to the human-specific traits of language (Crow,
1997), social cognition and interpersonal behavior (Burns, 2004,
2006), and increased brain size and changes in connectivity
(Horrobin, 1998). Further support for the latter has been found in
signatures of recent evolution in schizophrenia-associated genes
in humans (Crespi et al., 2007), however this was a targeted
study and since its publication new research has added to, and
refined, gene-disease associations. Positive selection on genes
associated with psychiatric disorders (Moalic et al., 2010) and
disease (Fay, 2013) in general has also been previously identi-
fied, although whether this constitutes a general trend remains
unclear.
A possible relationship between adaptation and common
genetic variation in the etiology of schizophrenia and autism
has been suggested since the first hereditary bases were observed
(Farley, 1976). Conceptually this work has progressed in parallel
with our understandings of complex genetic disease and molec-
ular evolution. Initially much of the focus was on proteins with
the belief that it was changes here that both drove the diseases
and evolutionary processes. It was realized, at least in theory, early
on that these dramatic changes in phenotype were more likely to
be due to changes in regulatory mechanisms (King and Wilson,
1975). More recently, both communities have come to appreciate
other sources of genetic variation. The role of copy number vari-
ation (CNV) in schizophrenia (Need et al., 2009; Stefansson et al.,
2009; Raychaudhuri et al., 2010; Malhotra et al., 2011) and autism
(Marshall et al., 2008; Bucan et al., 2009; Glessner et al., 2009;
Pinto et al., 2010) has grown significantly and the fact that there
is often significant overlap and balancing dosage effects between
the two at the same CNV loci has been crucial to the development
of the concept of a shared adaptive molecular etiology (Carroll
and Owen, 2009; Crespi et al., 2010; Owen et al., 2011; Crespi and
Crofts, 2012).
Here, we focus on the molecular evolution of protein-coding
genes associated with schizophrenia, autism, and other neuropsy-
chiatric diseases compared across mammalian species and among
disease classes, with a focus on the primate (chimpanzee, bonobo,
gorilla, orangutan, gibbon, macaque, baboon, marmoset, and
squirrel monkey) and human lineages. Recent genome wide asso-
ciation studies (GWAS) have identified multiple genomic loci
associated with autism (Ma et al., 2009; Wang et al., 2009; Weiss
et al., 2009; Anney et al., 2010, 2012; Tsang et al., 2013) and
Asperger syndrome (Salyakina et al., 2010), and schizophrenia
(Fanous et al., 2012; Levinson et al., 2012; Aberg et al., 2013; Ripke
et al., 2013). Using these datasets and similar meta-analyses in the
literature that have identified genes implicated in neuropsychi-
atric disease it is possible to test whether mutations have occurred
recently and uniquely in the evolution of humans, or whether
similar changes are seen in other mammals. Approximated using
ratios of non-synonymous (dN) to synonymous (dS) mutations in
the protein-coding regions of genes, signatures of recent positive
selection are evaluated. Evidence of differential selection on the
human lineage in genes associated with the neurodevelopmen-
tal disorders to the exclusion of other neuropsychiatric diseases
would support the hypothesis that these disorders are a cost of
the higher brain function observed in humans.
MATERIALS AND METHODS
GENES ASSOCIATED WITH NEUROLOGICAL AND PSYCHIATRIC
DISEASE
Genes associated with neurological and neuropsychiatric disease
were drawn from the Genetic Association Database (GAD; http://
geneticassociationdb.nih.gov/). This database is a publically-
maintained repository of published associations between genes
and complex diseases originating both from candidate gene stud-
ies as well as genome-wide association studies (Becker et al., 2004;
Zhang et al., 2010). At the time this study was initiated the GAD
included over 150,000 entries. This study focused on diseases
associated with the brain and/or behavior and ultimately included
1920 gene-disease pairings, genes may be associated with more
than one disease (Table 1). The nature of this approach is inten-
tionally agnostic as to the exhaustiveness of these gene lists. Not
only are these lists not likely to be complete, it is entirely possible
that false positives are included. Rather than force an attempt at
an unobtainable ideal, all putative positive associations have been
included. The implications of this approach and its relationship
to the results obtained are discussed herein.
Because of previous discussions in the literature, special atten-
tion was given to genes associated with schizophrenia and autism.
For these diseases more complete and highly curated lists of
associated genes are available.
The Schizophrenia Gene Resource (SzGR) is likewise a repos-
itory of more than 7500 genes showing links with schizophrenia
(Jia et al., 2010). This includes not only genes associated with the
disease but also those that undergo expression changes in cases
and gene network and pathway analyses integrating a wide variety
of data. Here, five subsets of these data are used for analysis: a core
list of 38 genes (Ross et al., 2006; Allen et al., 2008), a more inclu-
sive list of 278 protein-coding genes associated with schizophrenia
(Sun et al., 2008), a prioritized list of 75 associated genes by com-
bined odds ratio (COR) (Sun et al., 2008), or gene prioritization
(Sun et al., 2009) lists derived from two linkage meta-analyses:
(Lewis et al., 2003), 160 genes, or (Ng et al., 2009), 173 genes.
The Simons Foundation Autism Research Initiative (SFARI)
maintains a database of genes associated with autism spectrum
Table 1 | Number of genes from Genetic Association Database by
disease.
Disease Number of genes
Addiction 334
Alzheimer disease 254
Anxiety 18
Attention Deficit Hyperactivity Disorder (ADHD) 183
Autism/Asperger 34
Bipolar disorder 227
Depression 85
Eating disorder 14
Migraine 19
Parkinson disease 194
Schizophrenia 199
Stroke 341
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disorders (Basu et al., 2009). As of January 2014 this included
more than 500 genes, and more than half of these have been
scored by an expert advisory panel for the strength of their
evidence (Abrahams et al., 2013). This study uses 516 genes
including 303 with scores available.
A list of all genes used in this study and their categorization
can be found in supplemental materials (Table S1).
ORTHOLOG IDENTIFICATION
Forty-five species were used for the identification of orthologs
(Table 2): eleven primates including humans, 31 non-primate
eutherian mammals, two marsupials, and one monotreme.
Protein-coding sequences for each species were drawn from
RefSeq (Pruitt et al., 2014). Using BLAST (Boratyn et al., 2013),
best hits were identified for each species using the human
sequence and the universe of species-specific RefSeq target
sequences (Table S2). Putative orthologs with dS rates greater
than 4 standard deviations from the median for the human-
species pairwise comparison were flagged for manual curation
and removed from the data set as warranted (Vallender, 2009).
EVOLUTIONARY CALCULATIONS
Following ortholog identification nucleotide sequences were
translated into proteins and aligned using CLUSTALW (Larkin
et al., 2007). These aligned protein sequences were then used to
align the original nucleotide sequences in frame. Using a species
tree (Figure 1) generated by the NCBI Taxonomy Browser (NCBI
Resource Coordinators, 2014) as a guide, PAML (Yang, 2007) was
used to calculate dN and dS for all lineages. Default values within
the PAML control files were used. For each gene four models were
run: a single dN/dS for all branches, a branch model compar-
ing catarrhine branches to all others, a branch model comparing
catarrhine and cetacean branches to all others, and a free ratio
model (Table S3). Results were not significantly different when a
more nuanced tree (Meredith et al., 2011), or when the Nei and
Gojobori method was used (Nei and Gojobori, 1986). To calculate
average dN/dS for groups of genes, such as those associated with
a specific disorder, the average of dN divided by the average of dS,
dN/dS, was used rather than the average of dN/dS, (dN/dS), after
previous work (Vallender and Lahn, 2007). This method of calcu-
lation better represents evolutionary constraint on the group of
genes particularly in short lineages up against the zero bound for
dS where stochastic noise is large relative to the expected value.
STATISTICAL CALCULATIONS
Statistical comparisons were made using One-Way ANOVA
between all lineage pairs with Bonferroni correction for multiple
tests. This method results in a conservative estimation of signifi-
cance, but one without any a priori biases. Summaries of statistical
significance are offered in the text, but readers wanting additional
information are referred to Supplemental Tables 4–6.
RESULTS
This study sought to understand the evolutionary conservation
among genes associated with mental health disorders. It made
use of genomes from 42 eutherians and 3 monotreme and mar-
supial outgroups. For each gene, orthologs were identified where
Table 2 | Species used in the study.
Species Common name
Monotremes Ornithorhynchus anatinus Platypus
Marsupials Monodelphis domestica Gray short-tailed opossum
Sarcophilus harrisii Tasmanian devil
Eutheria
Xenarthra Dasypus novemcinctus Nine-banded armadillo
Afrotheria Trichechus manatus
latirostris
Florida manatee
Echinops telfairi Small Madagascar
hedgehog
Loxodonta africana African savanna elephant
Laurasiatheria
Eulipotyphla Condylura cristata Star-nosed mole
Sorex araneus European shrew
Perissodactyla Equus caballus Horse
Ceratotherium simum
simum
Southern white rhinoceros
Cetartiodactyla Sus scrofa Pig
Bos taurus Cow
Ovis aries Sheep
Orcinus orca Killer whale
Tursiops truncatus Bottlenosed dolphin
Carnivora Felis catus Cat
Canis lupus familiaris Dog
Mustela putorius furo Ferret
Ailuropoda melanoleuca Giant panda
Odobenus rosmarus
divergens
Pacific walrus
Euarchontoglires
Lagomorpha Oryctolagus cuniculus Rabbit
Ochotona princeps American pika
Rodentia Chinchilla lanigera Long-tailed chinchilla
Heterocephalus glaber Naked mole-rat
Octodon degus Degu
Cavia porcellus Guinea pig
Jaculus jaculus Lesser Egyptian jerboa
Ictidomys
tridecemlineatus
Thirteen-lined ground
squirrel
Microtus ochrogaster Prairie vole
Mesocricetus auratus Golden hamster
Cricetulus griseus Chinese hamster
Rattus norvegicus Rat
Mus musculus Mouse
Primates Otolemur garnettii Small-eared galago
Saimiri boliviensis
boliviensis
Bolivian squirrel monkey
Callithrix jacchus White-tufted-ear
marmoset
Macaca mulatta Rhesus macaque
Papio anubis Olive baboon
Nomascus leucogenys Northern white-cheeked
gibbon
Pongo abelii Sumatran orangutan
Gorilla gorilla gorilla Western lowland gorilla
Pan troglodytes Chimpanzee
Pan paniscus Bonobo (pygmy
chimpanzee)
Homo sapiens Human
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FIGURE 1 | Species tree. Species tree, generated by NCBI Taxonomy Browser, used as a guide in PAML for the calculation of dN and dS values under the free
ratio model. Lineages presented in this study are bolded. Great ape species are shown in red for ease of comparison. Notable clades discussed herein are shown.
possible and the protein sequences aligned. Evolutionary param-
eters, including mutation rates at synonymous (dS) and non-
synonymous sites (dN), and measures of evolutionary constraint
(dN/dS) were calculated for each branch. Prior to any attempt
at interpreting the data, two issues of importance need to be
addressed: the identification of genes under study and the lineages
under focus.
A pervasive difficulty in any attempt to study the genetics
underlying a particular disease is first in developing a list of genes
responsible for the disease. This is already challenging for com-
plex polygenic diseases where phenotypic delineations are clear.
For mental health disorders where symptomology and diagno-
sis are more problematic, it is a significant issue. Lists of genes
associated with these diseases are almost certainly incomplete
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and likely will see disagreement even among experts. An advan-
tage of using a literature-derived aggregator like the Genetic
Association Database (GAD) is that it is unbiased, even at the
cost of potentially including what ultimately may prove to be false
positives.
The evolutionary constraint for the terminal branches of
each of the eutherians are compared with the exception of the
armadillo (Dasypus novemcinctus), the only species lacking an
intra-ordinal comparison. Afrotherian phylogenetics and species
representation poses difficulties as well (Seiffert, 2007) compli-
cating direct comparisons among those species pairs and those
of Boreoeutheria. Internal branches likewise proved difficult to
analyze due in part to missing orthologs causing the collapse of
multiple branches into one. Internal branches are also quanti-
tatively different than terminal branches; terminal branches not
only are more likely to include sequencing artifacts, but they are
also likely, especially in situations where few exemplars were used
in the genome building process, to include polymorphisms des-
tined to be eliminated by selection (genetic load). Because these
events are biased toward non-synonymous mutations, they artifi-
cially raise the apparent dN/dS. While this pattern of effects is the
same across genes and gene categories, it is not necessarily directly
comparable across species making it important that these issues
be taken into account when interpreting findings.
While genes associated with schizophrenia and autism based
on positive associations in the GAD (Figure 2) reveal no signif-
icant signal of positive selection on the human branch relative
to apes or other primates, catarrhines in general show higher
average dN/dS when compared to other mammals, with the
exception of the cetaceans (Tursiops truncatus and Orcinus orca).
Among the schizophrenia-associated genes, catarrhines tend to
show a significant difference in dN/dS relative to most sciurog-
naths (p < 0.05), with similar although non-significant trends
when compared to the other rodents, lagomorphs, carnivores,
and insectivores (Eulipotyphla). Among the autism-associated
genes, results are trending in a similar direction, however the sig-
nal contains more noise likely due to the fewer number of genes
analyzed. The cetaceans, especially the dolphin branch, show sig-
nificantly different evolutionary constraint on genes associated
with schizophrenia and autism, with a greater average dN/dS than
almost all other mammals.
Among other neurological disorders similar results are seen
(Figure 3). The general pattern observed in genes associated with
schizophrenia are seen in ADHD, bipolar disorder, addiction, and
the neurodegenerative disorders (Alzheimers and Parkinsons),
though as with autism the difference is less. Only in genes asso-
ciated with anxiety, eating disorders, and migraine is this broad
pattern not seen and in depression it is greatly diminished. With
each of these categories it may simply be the result of small num-
bers of genes, but genes associated with anxiety and migraine
are noticeably and dramatically more conserved across all species
suggesting perhaps a different selective regime. Despite their
neurological effects, genes associated with stroke are largely vas-
cularly, not neuronally, expressed, and therefore serve as a useful
control for the other neurological diseases. While muted, it too
shows similar patterns as seen in schizophrenia and the majority
of the other mental health disorders.
As previously noted, one potential difficulty in these analyses
is in the identification of specific genes associated with disease.
Focusing specifically on schizophrenia and autism, the two dis-
eases hypothesized to be associated with the evolution of the
human brain, additional gene lists were sought out to confirm
and develop these findings. The Schizophrenia Gene Resource
(SzGR, Jia et al., 2010) and Simons Foundation Autism Research
Initiative Gene (SFARI, Basu et al., 2009) both contain gene
FIGURE 2 | Average dN/dS across taxa of genes associated with
schizophrenia and autism. Average dN/dS of genes positively associated
with schizophrenia (top) and autism (bottom) based on positive
gene-disease associations collated by the Genetic Association Database
(GAD) are depicted. Average dN/dS ratios suggest changes in selective
regime in catarrhines and dophin in genes associated with these
neurodevelopmental diseases. Pairwise significance values are shown in
Supplemental Table 4.
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FIGURE 3 | Average dN/dS across taxa of genes associated with
other neurological diseases and controls. Average dN/dS of genes
positively associated with other neurological diseases (ADHD, bipolar
disorder, depression, anxiety, addiction, eating disorders, Alzheimers,
and Parkinsons, migraine) and control (stroke) based on positive
gene-disease associations in the Genetic Association Database (GAD)
are depicted. Average dN/dS ratios reveal a similar pattern of
evolution in catarrhines and dophin as was seen with schizophrenia
and autism, to the exclusion of anxiety, eating disorder, and
migraine which depict broad evolutionary conservation across all
evaluated mammalian taxa. Pairwise significance values are shown in
Supplemental Table 4.
FIGURE 4 | Average dN/dS across taxa of SzGR schizophrenia-
associated genes. Average dN/dS of genes positively associated with
schizophrenia based on associations collected in the Schizophrenia Gene
Resource (SzGR). Average dN/dS ratios suggest changes in selective
regime in catarrhines and dophin similar to the GAD gene set. Pairwise
significance values are shown in Supplemental Table 5.
lists maintained and curated by disease experts and are therefore
potentially more complete and accurate.
When the genes listed by SzGR as associated with schizophre-
nia are examined (Figure 4), an almost identical pattern emerges
compared to the GAD genes. Again, the dolphin shows signifi-
cantly greater dN/dS values than other mammals and catarrhine
dN/dS values are elevated, reaching significance in some compar-
isons. Interestingly, these patterns are ensmalled when attempts
are made to prioritize the genes and identify those that are most
important (Figure S1). It is possible that this results from the
approaches taken to prioritization, but it also may suggest that
those genes more central to the disease have a distinct signature
of conservation.
Using the SFARI dataset for autism genes, a much more
robust recapitulation of the GAD pattern is observed (Figure 5).
Although the average dN/dS on the human branch remains equal
to or less than the other apes and old world monkeys, overall the
catarrhines, including humans, maintain a significantly greater
average dN/dS when compared to the insectivores (p < 0.001),
some carnivores (p < 0.05), most rodents (p < 0.05), and the
lagomorphs (p < 0.01). Genes for syndromic and non-syndromic
autism were also evaluated separately with no difference in the
overall result pattern (Figure S2), except perhaps a greater sig-
nal and larger error among the apes and old world monkeys
in syndromic autism. Analyses were also performed on scored
datasets (Figure S3), where increasing level of confidence in genes
associated with autism revealed few differences in the overall
results.
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FIGURE 5 | Average dN/dS across taxa of SFARI autism-associated
genes. Average dN/dS of genes positively associated with autism based on
associations collected in Simons Foundation Autism Research Initiative
Gene (SFARI). Average dN/dS ratios suggest changes in selective regime in
catarrhines and dophin similar to what is observed for schizophrenia gene
sets but a stronger pattern than observed in the GAD autism gene set.
Pairwise significance values are shown in Supplemental Table 6.
DISCUSSION
Our understanding of neurodevelopmental disorders has led to
the hypothesis that diseases like schizophrenia and autism are
uniquely human. The implication stemming from this idea is that
identifying the genes underlying the diseases will also identify the
genetic changes that have led, at least in part, to the evolution
of the human brain. Through evaluation of the molecular evo-
lution of genes associated with schizophrenia and autism, it is
possible to detect signatures of positive selection. In this study,
however, elevated dN/dS values in genes associated with these dis-
eases were not restricted to the human branch, and instead were
seen not only in humans and apes, but in the old world monkeys
and dolphins as well.
Elevated dN/dS values by themselves are not proof of pos-
itive selection, because relaxation of selective constraint would
produce similar results. Positive selection on a gene also can be
obscured by differences in selective pressures across time or by
differences in pressures in different protein regions. Furthermore,
here, when considering classes of genes, an additional factor is
present; some genes within a class may be under positive selec-
tion while others may not. Nevertheless, the very nature of the
genes and their association with significant diseases makes it
unlikely that they are under relaxed constraint. It remains that
these effects could be of demographic origins, resulting from inef-
ficient selective pressures due to reduced effective population sizes
or lineage lengths. This is given credence in part because a similar,
if weakened, pattern of selection was also observed in non-
neurodevelopmental diseases with few differences distinguishing
schizophrenia and autism from ADHD, bipolar disease, the
neurodegenerative diseases, addiction, and the control pathol-
ogy of stroke. Because these latter diseases have not been sug-
gested to be a unique consequence of human evolution there
is less reason to expect selective pressures leading to the same
pattern. Indeed the conservation observed in the genes associ-
ated with migraine and anxiety is much more similar to the
expected control, with strong conservation across all species.
These findings also broadly follow the expectations of the nearly-
neutral model of molecular evolution (Ohta, 1995; Akashi et al.,
2012).
Genome quality may also be a partial cause of this effect.
Certainly poor quality genomes would be expected to show higher
dN/dS as errors would fall neutrally on genes. Even without
sequencing errors, genomes constructed using few individuals
can appear to have artificially higher dN/dS values because of an
inability to exclude slightly deleterious mutations. The human
genome is by far the best studied and its consensus is based on
a much greater number of individuals, therefore the apparent
genetic load on this branch is likely less than the other mam-
mals, dampening the signal of positive selection relative to the
other taxa. Many, though not all, of the other species for which
genomes are available use fewer individuals. Additionally several
of the species for which genomes are available have recent his-
tories of artificial selection, whether through domestication (pig,
cow, sheep, cat, and dog) or laboratorization (mouse and rat),
that may have fixed some level of genetic load.
Regardless, the signals that are observed are not unique to
humans; rather we see similar patterns across catarrhines and
cetaceans. This may suggest that any changes in selective regime
on genes associated with these diseases is a result of a shared elab-
oration; in fact, toothed cetaceans and primates are known to
share similar patterns of molecular evolution (McGowen et al.,
2012), relaxation of constraint on encephalization, and an over-
all greater brain to body mass ratio when compared to other
mammalian taxa (Boddy et al., 2012), a phenotype potentially
attributed to enhanced social behavior (Connor, 2007). Likewise,
positive selection on genes associated with nervous system pro-
cesses including synaptic plasticity, sleep, and intellectural disabil-
ities including schizophrenia have also been previously detected
in dolphins (McGowen et al., 2012). Notably, however, other
large-brained taxa evaluated in this study, including elephants,
bears, and rhinoceroses, did not show similar differences, sug-
gesting that the changes observed are not simply the result
of changes in brain size. Furthermore consistent differences in
evolutionary constraint are seen in catarrhines relative to the
sciurognaths, which include laboratory rodents Mus musculus
and Rattus norvegicus. This result might suggest increased cau-
tion when using these animals as models of neuropsychiatric
disease.
Thus although these results suggest that selection on the genes
associated with schizophrenia and autism is not associated with
humans alone, the tenuousness or absence of neurodevelopmen-
tal disease analogs in other species remains an important consid-
eration, and therefore may point at potential limitations in study
design, including the gene-disease association lists themselves.
Given the polygenic nature of neuropsychiatric diseases, the
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broad spectrum of phenotypes that represent disease, and the
continued limited understanding of the molecular mechanism by
which diseases are triggered, genes with weak, or unconfirmed
associations included in the analysis have the potential to mask
a signal of positive selection. Furthermore, if genes strongly asso-
ciated with the disease have not yet been identified, then a signal
of positive selection may again be weakened. This is supported at
least in part by the changes seen in genes associated with autism
when the SFARI gene list is used.
Lastly, it is also possible that a signal for positive selection
on the human branch was missed in this analysis because neu-
rodevelopmental disorders result not from changes in the genes
themselves, but instead from changes in regulatory regions or
variation in copy number. Although positive selection in protein-
coding regions of genes associated with language (FOXP2, Enard
et al., 2002) and brain size (MCPH1, Evans et al., 2004a; Wang
and Su, 2004); ASPM, (Zhang, 2003; Evans et al., 2004b; Kouprina
et al., 2004) have been found in humans, this may be because
these changes are easier to identify at present. Temporal or spa-
tial changes in expression patterns or changes in the amplitude
of expression of the genes may show differences across mam-
mals and are perhaps more likely to be uniquely different in
humans (King and Wilson, 1975). Haygood et al. (2007), for
instance, found a human-specific signature of positive selection
in promoter regions of genes associated with neural develop-
ment and function as well as in neurodegenerative diseases.
Studies of structural variation have also found indications of
brain-related evolutionary effects in humans (Cooper et al.,
2007); and copy number variation of the DUF1220 domain
has been associated with both autism severity (Davis et al.,
2014) and brain-size evolution in primates (Popesco et al.,
2006; Dumas et al., 2012). It may be that while the proteins
associated with schizophrenia and autism are indeed conserved
between humans and other mammals, their expression has
diverged.
One implication of these results may be that when we study
neurodevelopmental disorders from an evolutionary standpoint
we should not be focusing on proteins. Rather, those aspects of
the disease that may represent an adaptive evolutionary response
are found in other genetic moieties, either in regulatory regions
or in structural and copy number variation. It is perhaps worth
considering if this represents a unique situation in the neurode-
velopmental diseases or if it is simply a reflection of more general
patterns of adaptive evolution. It is also perhaps relevant to our
understandings of the neurodevelopmental diseases themselves.
If the evolutionary changes associated with the disease are to be
found outside of proteins, then are we also more likely to find
treatments or cures there?
Although these data suggest that genes associated with neu-
rodevelopmental disease are not evolving uniquely in humans,
the study is potentially limited by the completeness and accuracy
of gene-disease association lists available and by the methodol-
ogy of the study that focuses on protein-coding regions. Rather
than refute the hypothesis, however, it may point toward a greater
importance for changes in expression, in promoters and/or tran-
scription factor binding sites, or in epigenetic markings in the
lineage leading to humans.
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